You are now leaving the Grünenthal (UK) website. You will be re-directed to an external website. Grünenthal UK Ltd. accepts no responsibility for the content of other websites.
We focus on ensuring an ethical business culture including adherence to legal requirements and industry standards, the responsible use of AI, and addressing industry specific risks such as corruption and bribery.
The Grünenthal Code of Conduct sets out our commitment to the highest ethical standards. Everybody in our organisation has the responsibility to live up to these standards in their daily work. All employees sign the Code of Conduct when joining Grünenthal.
We are committed to ethical business practices, and we only work with business partners who uphold the same high standards. To ensure this, we established our Code of Conduct for Business Partners, which must be signed before formally entering into a partnership.
We encourage everyone to report any questions, doubts or suspicions they may have by contacting our Ethics Helpline. The confidential internet-based platform can be used 24/7.
Every complaint or concern is investigated by our Compliance team. We take appropriate action whenever necessary.
We encourage the reporting of misconduct through our internal reporting channels. However, countries have designated authorities that serve as channels for whistleblowers. Please find a list of external reporting channels here.
Grünenthal’s Charter on the Responsible Use of Opioids sets out our commitment to exploring and endorsing measures that minimise the risk of inappropriate and illegitimate use of prescription opioids – while striving to ensure that individual patients with a clear need for opioid-based pain relief are not denied access.
We are committed to conducting business in a legal, ethical and honest manner. We have a strict Anti-Corruption Policy, a Fair Market Value Tool and strict approval processes for transfers of value. These measures ensure that we do not tolerate corruption in any form.
We handle all personal data responsibly. We conduct all of our data processing activities in line with applicable legal standards such as the GDPR, and we also adhere to the principles laid out in our Digital Ethics Charter and Data Protection Policy.
We are committed to conducting our research activities in line with our strict Bio Ethics Framework. We adhere to clear rules for animal testing, human biological sampling and the use of other emerging technologies.
Grünenthal is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and supports the EFPIA Disclosure (Transparency) Code. The Association of the British Pharmaceutical Industry (the ABPI) has stipulated additional reporting requirements in its Code of Practice for the Pharmaceutical Industry, therefore a modified version of the EFPIA template is in use in the UK. The ABPI Code requires all member companies to disclose their data using a central portal hosted by the ABPI. Information regarding the disclosure of transfers of value in the UK can be accessed directly from the ABPI Website.
Support provided to patient organisations is not disclosed within the central report. To see details of the support provided by Grünenthal to patient organisations and other groups in our local community, please click here.